These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6685490)

  • 1. Absorption and tissue distribution of flunarizine in rats, pigs and dogs.
    Michiels M; Hendriks R; Knaeps F; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1983; 33(8):1135-42. PubMed ID: 6685490
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion and metabolism of flunarizine in rats and dogs.
    Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
    Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agents to improve cerebrovascular circulation and cerebral metabolism--flunarizine].
    Kurihara J; Kato H
    Nihon Rinsho; 1985 Feb; 43(2):402-5. PubMed ID: 3889415
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitive gas chromatographic method for the determination of cinnarizine and flunarizine in biological samples.
    Woestenborghs R; Michielsen L; Lorreyne W; Heykants J
    J Chromatogr; 1982 Oct; 232(1):85-91. PubMed ID: 7142341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability in man of oral formulations of flunarizine (drops and capsules)].
    De Caro G; Maggi L
    Boll Chim Farm; 1984 Oct; 123(10):65S-70S. PubMed ID: 6529492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics and metabolism of the antihypertensive agent urapidil in rats and dogs].
    Ludwig G; Vergin H; Zech K
    Arzneimittelforschung; 1977; 27(11):2077-86. PubMed ID: 580005
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H; Kurihara J; Ishii K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique.
    Borgers M; Thoné F; van Nueten JM
    Acta Histochem Suppl; 1981; 24():327-32. PubMed ID: 6165047
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug.
    Noda K; Noguchi H; Okui M; Tada K; Morimoto Y
    Arzneimittelforschung; 1972 Apr; 22(4):732-43. PubMed ID: 4626080
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain protective properties of etomidate and flunarizine.
    Wauquier A
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S53-6. PubMed ID: 7085800
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of Morocromen in animals and man (author's transl)].
    Dell HD; Jacobi H; Kamp R; Lorenz D
    Arzneimittelforschung; 1982; 32(5):492-8. PubMed ID: 7201825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, and excretion of fluproquazone in several animal species.
    Williams JI; Bhuta SI; Jaffe JM; Migdalof BH; Schwarz HJ; Talbot KC; Brouillard JF; Donatsch P; Hodel C; Lemaire M; Meier J; Schweitzer A
    Arzneimittelforschung; 1981; 31(5a):897-904. PubMed ID: 6973983
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of treatment of migraine patients with cinnarizine and flunarizine].
    Drillisch C; Girke W
    Med Welt; 1980 Dec; 31(51-52):1870-2. PubMed ID: 6110158
    [No Abstract]   [Full Text] [Related]  

  • 18. A cardiac arrest model in rats for evaluating the antihypoxic action of flunarizine.
    Hermans C; De Reese R; Van Loon J; Loots W; Jageneau AH
    Eur J Pharmacol; 1982 Jun; 81(1):137-40. PubMed ID: 7117366
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):201-8. PubMed ID: 9079241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.